A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

January 3, 2020

Study Completion Date

January 3, 2020

Conditions

Symptomatic Obstructive Hypertrophic CardiomyopathyHealthy Subjects

Interventions

DRUG

CK-3773274 - Granules in Capsule

CK-3773274 formulated as granules in capsule

DRUG

Placebo - Granules in Capsule

Placebo formulated as granules in capsule

DRUG

CK-3773274 - Tablets

CK-3773274 formulated as tablets

Trial Locations (1)

Clinical Site, Tempe